Eugenia Monferini

1.2k total citations
31 papers, 1.0k citations indexed

About

Eugenia Monferini is a scholar working on Molecular Biology, Cellular and Molecular Neuroscience and Oncology. According to data from OpenAlex, Eugenia Monferini has authored 31 papers receiving a total of 1.0k indexed citations (citations by other indexed papers that have themselves been cited), including 23 papers in Molecular Biology, 17 papers in Cellular and Molecular Neuroscience and 5 papers in Oncology. Recurrent topics in Eugenia Monferini's work include Receptor Mechanisms and Signaling (18 papers), Neuropeptides and Animal Physiology (10 papers) and Neuroscience and Neuropharmacology Research (6 papers). Eugenia Monferini is often cited by papers focused on Receptor Mechanisms and Signaling (18 papers), Neuropeptides and Animal Physiology (10 papers) and Neuroscience and Neuropharmacology Research (6 papers). Eugenia Monferini collaborates with scholars based in Italy, France and Germany. Eugenia Monferini's co-authors include E. Giraldo, H. Ladinsky, Rudolf Hammer, G.B. Schiavi, Franco Borsini, Marina Volonté, Marco Turconi, Aline Dumuis, L. Manara and Joël Bockaert and has published in prestigious journals such as Biochemical and Biophysical Research Communications, Journal of Neurochemistry and Biochemical Pharmacology.

In The Last Decade

Eugenia Monferini

31 papers receiving 973 citations

Peers

Countries citing papers authored by Eugenia Monferini

Since Specialization

Citations

This map shows the geographic impact of Eugenia Monferini's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Eugenia Monferini with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Eugenia Monferini more than expected).

Fields of papers citing papers by Eugenia Monferini

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Eugenia Monferini. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Eugenia Monferini. The network helps show where Eugenia Monferini may publish in the future.

Co-authorship network of co-authors of Eugenia Monferini

This figure shows the co-authorship network connecting the top 25 collaborators of Eugenia Monferini. A scholar is included among the top collaborators of Eugenia Monferini based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Eugenia Monferini. Eugenia Monferini is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Functionalized Cyclic RGD Peptidomimetics: Conjugable ligands for α_vβ₃ Receptor Imaging 2009 ·Bioconjugate Chemistry ·Daniela Arosio, Leonardo Manzoni, (unknown), Andréa Caprini, Eugenia Monferini, Carlo Scolastico	24
2	Cyclic RGD‐Containing Functionalized Azabicycloalkane Peptides as Potent Integrin Antagonists for Tumor Targeting 2009 ·ChemMedChem ·Leonardo Manzoni, Laura Belvisi, Daniela Arosio, Monica Civera, (unknown), Donatella Potenza, Andréa Caprini, (unknown), Eugenia Monferini, Monica Mancino, F Podestà, Carlo Scolastico	39
3	RNA-Mediated Interference Indicates that SEL1L Plays a Role in Pancreatic β -Cell Growth 2004 ·DNA and Cell Biology ·Giuseppe R. Diaferia, Monica Cattaneo, (unknown), Maria Carla Proverbio, Eugenia Monferini, Giulia Malferrari, Alberto Albertini, Ida Biunno	7
4	Identification of a novel polymorphism in the fibronectin type II domain of the SEL1L gene and possible relation to the persistent hyperinsulinemic hypoglycemia of infancy 2004 ·Mutation research. Fundamental and molecular mechanisms of mutagenesis ·(unknown), Maria Carla Proverbio, Giulia Malferrari, (unknown), P. Boettcher, Roberto Dominici, Eugenia Monferini, (unknown), Monica Cattaneo, Davide Antonello, (unknown), I. Zamproni, Matteo Viscardi, G Chiumello, Ida Biunno	4
5	Ctla4 and multiple sclerosis in the Italian population 2004 ·Experimental and Molecular Pathology ·Giulia Malferrari, Alessandro Stella, Eugenia Monferini, (unknown), Maria Carla Proverbio, Luigi Grimaldi, L. Rossi-Bernardi, Ida Biunno	24
6	High-Quality Genomic DNA from Human Whole Blood and Mononuclear Cells 2002 ·BioTechniques ·Giulia Malferrari, Eugenia Monferini, Pasquale De Blasio, Giuseppe R. Diaferia, (unknown), (unknown), L. Rossi-Bernardi, Ida Biunno	36
7	Ex vivo binding of flibanserin to serotonin 5-HT1 Aand 5-HT2Areceptors 2001 ·Pharmacological Research ·(unknown), Eugenia Monferini, Franco Borsini	13
8	Flibanserin < Prop INN > 1998 ·Drugs of the Future ·Franco Borsini, A. Brambilla, Angelo Ceci, (unknown), E. Giraldo, (unknown), Eugenia Monferini, Marco Turconi	11
9	BIMG 80, a Novel Potential Antipsychotic Drug: Evidence for Multireceptor Actions and Preferential Release of Dopamine in Prefrontal Cortex 1997 ·Journal of Neurochemistry ·Marina Volonté, Eugenia Monferini, (unknown), (unknown), Franco Borsini	80
10	BIMT 17, a 5-HT2A receptor antagonist and 5-HT1A receptor full agonist in rat cerebral cortex 1995 ·Naunyn-Schmiedeberg s Archives of Pharmacology ·Franco Borsini, E. Giraldo, Eugenia Monferini, Giovanni Antonini, Marco Parenti, (unknown), A. Donetti	41
11	Medicinal chemistry of muscarinic agonists for the treatment of dementia disorders 1994 ·European Journal of Drug Metabolism and Pharmacokinetics ·(unknown), A. Brambilla, (unknown), Wolfram Gaida, Klaus Mendla, Eugenia Monferini, Nikolaos Pitsikas, G.B. Schiavi, A. Sagrada	6
12	Pharmacological characterization of the 5-hydroxytryptamine receptor coupled to adenylyl cyclase stimulation in human brain 1993 ·Life Sciences ·Eugenia Monferini, Paolo Gaetani, Riccardo Rodriguez y Baena, E. Giraldo, Marco Parenti, (unknown), C.A. Rizzi	30
13	Characterization of a novel 5-HT4 receptor antagonist of the azabicycloalkyl benzimidazolone class: DAU 6285 1992 ·Naunyn-Schmiedeberg s Archives of Pharmacology ·Aline Dumuis, H. Gozlan, Michèle Sebben, Hervé Ansanay, C.A. Rizzi, Marco Turconi, Eugenia Monferini, E. Giraldo, P Schiantarelli, H. Ladinsky, Joël Bockaert	46
14	The orphan receptor cDNA RDC4 encodes a 5-HT1D serotonin receptor 1991 ·Biochemical and Biophysical Research Communications ·Carine Maenhaut, J. Van Sande, C. Massart, Christiane Dinsart, Frédérick Libert, Eugenia Monferini, E. Giraldo, H. Ladinsky, Gilbert Vassart, J.E. Dumont	33
15	Azabicycloalkyl benzimidazolone derivatives as a novel class of potent agonists at the 5-HT4 receptor positively coupled to adenylate cyclase in braina 1991 ·Naunyn-Schmiedeberg s Archives of Pharmacology ·Aline Dumuis, Michèle Sebben, Eugenia Monferini, Massimo Di Nicola, Marco Turconi, H. Ladinsky, Joël Bockaert	42
16	Chapter 21 Pharmacological muscarinic receptor subtypes 1990 ·Progress in brain research ·H. Ladinsky, G.B. Schiavi, Eugenia Monferini, (unknown)	11
17	Guanylpirenzepine Distinguishes Between Neuronal m1 and m4 Muscarinic Receptor Subtypes 1990 ·Journal of Receptor Research ·Eugenia Monferini, (unknown), H. Ladinsky, A. Donetti, E. Giraldo	3
18	Characterization of the muscarinic receptor subtypes in the rat urinary bladder 1988 ·European Journal of Pharmacology ·Eugenia Monferini, E. Giraldo, H. Ladinsky	55
19	Characterization of muscarinic receptors in salivary and lacrimal glands of the rat 1987 ·European Journal of Pharmacology ·Francisco Martos Crespo, Eugenia Monferini, E. Giraldo, (unknown), Rudolf Hammer	27
20	Muscarinic receptor heterogeneity in guinea pig intestinal smooth muscle: binding studies with AF-DX 116 1987 ·European Journal of Pharmacology ·E. Giraldo, Eugenia Monferini, H. Ladinsky, Rudolf Hammer	63

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact